Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia.

Chung JW, Choi SH, Kim BS, Kim TH, Yoo ES, Kim CI, Lee KS, Kwon TG.

Korean J Urol. 2011 Jul;52(7):479-84. doi: 10.4111/kju.2011.52.7.479. Epub 2011 Jul 24.

2.

Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia : a nonblind multicentre korean study.

Park CH, Chang HS, Oh BR, Kim HJ, Sul CK, Chung SK, Jung SI.

Clin Drug Investig. 2004;24(1):41-7.

PMID:
17516689
4.
7.

A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients.

Okada H, Kamidono S, Yoshioka T, Okuyama A, Ozono S, Hirao Y, Okajima E, Yamamoto K, Kishimoto T, Park Y, Kurita T.

BJU Int. 2000 Apr;85(6):676-81.

9.
11.

The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality.

Gorgel SN, Sefik E, Kose O, Olgunelma V, Sahin E.

Int Braz J Urol. 2013 Sep-Oct;39(5):657-62. doi: doi: 10.1590/S1677-5538.IBJU.2013.05.07.

12.
13.

Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function.

Seo DH, Kam SC, Hyun JS.

Korean J Urol. 2011 Jan;52(1):49-54. doi: 10.4111/kju.2011.52.1.49. Epub 2011 Jan 24.

15.

Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.

Kaplan SA, Roehrborn CG, Chancellor M, Carlsson M, Bavendam T, Guan Z.

BJU Int. 2008 Nov;102(9):1133-9. doi: 10.1111/j.1464-410X.2008.07761.x. Epub 2008 May 26.

16.

Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

Yu HJ, Lin AT, Yang SS, Tsui KH, Wu HC, Cheng CL, Cheng HL, Wu TT, Chiang PH.

BJU Int. 2011 Dec;108(11):1843-8. doi: 10.1111/j.1464-410X.2011.10233.x. Epub 2011 May 18.

19.

[Combination of tolterodine and tamsulosin for benign prostatic hyperplasia].

Wu ZL, Geng H.

Zhonghua Nan Ke Xue. 2009 Jul;15(7):639-41. Chinese.

PMID:
19694381
20.

Efficacy and Safety of the Selective α1A-Adrenoceptor Blocker Silodosin for Severe Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective, Single-Open-Label, Multicenter Study in Korea.

Moon KH, Song PH, Yang DY, Park NC, Kim SW, Lee SW, Kim SW, Moon du G, Park JK, Ahn TY, Park K.

Korean J Urol. 2014 May;55(5):335-40. doi: 10.4111/kju.2014.55.5.335. Epub 2014 May 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk